Nishimura Y, Maiocco J, Janda G, Nedved A, Han Y, Durani U, Nowakowski GS, Paludo J, Thanarajasingam G, Micallef I, Johnston P, Witzig T, Habermann T, Maurer M, Armand P, Ansell SM, Abeykoon J. Clinical outcomes and safety of the immune checkpoint inhibitor rechallenge in Hodgkin lymphoma: an off-trial analysis. haematol [Internet]. 2020Sep.10 [cited 2026Sep.26];. Available from: https://haematologica.org/article/view/14442